Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual SNOAC for Blood Pressure in Healthy Volunteers
NCT05798481Phase 1Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Mar 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of sodium nitrite and acetylcysteine in hypertension (HTN), sponsored by University of Alabama at Birmingham. Primary endpoints: Measurement of plasma nitrite, nitrate and S-nitrosothiols up to 18 months and Systemic systolic and diastolic blood pressure up to 11 months. Started Mar 2024; status: completed.
02
Drugs
sodium nitriteacetylcysteine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05798481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05798481.